Sally Dabelsteen

Sally Dabelsteen

Associate Professor, Associate Professor - Promotion Programme

Member of:


    1. 2018
    2. Published

      Truncated mucin type O-Glycans in Epithelial Cancers: Central Drivers or Blind Passengers?

      Rømer, T. B., Pallesen, E. M. H., Levann, Asha Maria Rudjord, Dylander, A. A. N., Haue, Amalie Dahl, Li, Minyan, Dabelsteen, Sally & Wandall, Hans H., 28 Aug 2018.

      Research output: Contribution to conferencePosterResearchpeer-review

    3. Published
    4. Published

      Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

      Mathiesen, C. B. K., Carlsson, M. C., Brand, S., Möller, S. R., Idorn, M., Straten, P. T., Pedersen, Anders Elm, Dabelsteen, Sally, Halim, Adnan, Würtzen, P. A., Brimnes, J., Ipsen, H., Petersen, Bent L & Wandall, Hans H., 2018, In: Journal of Allergy and Clinical Immunology. 142, 6, p. 1983-1987

      Research output: Contribution to journalLetterResearchpeer-review

    5. Published

      Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin

      Woetmann, Anders , Alhede, M., Dabelsteen, Sally, Bjarnsholt, Thomas, Rybtke, Morten Levin, Nastasi, C., Krejsgaard, T., Andersen, Mads Hald, Bonefeld, Charlotte Menne, Geisler, Carsten, Givskov, Michael & Ødum, Niels, 2018, In: OncoTarget. 9, 28, p. 19481-19489 9 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    ID: 11286